SPI
NEUTRALSpire Healthcare Directors Exercise Sharesave Options
The healthcare provider announces its CEO and CFO have exercised Sharesave options, acquiring additional shares in the company.
Spire Healthcare Group
225.50GBX
0.89%
Market Cap
921.56M
Volume
27.78k
3% of avg
P/E Ratio
0.15
EPS (TTM)
14.88
Beta
0.66
Day Range
222.50p - 228.00p
52 Week Range
168.20p225.50p263.00p
225.50p
Upcoming Events
SPI
NEUTRALSpire Healthcare Announces Regulatory Disclosure
The healthcare provider has made a regulatory disclosure regarding a change in major shareholding.
SPI
NEUTRALSpire Healthcare Grants LTIP Awards to CFO
The healthcare provider has granted performance share awards to its CFO under the company's Long Term Incentive Plan.
SPI
NEUTRALSpire Healthcare Announces Holding Change
The healthcare provider has announced a change in shareholding, with FIL Limited increasing its stake in the company.
SPI
NEUTRALSpire Healthcare Delivers Trading Update in Line with Expectations
The healthcare provider reports trading in line with expectations, with its transformation programme on track to deliver £30m in efficiencies this year.
SPI
NEUTRALSpire Healthcare Directors Exercise Share Awards
The healthcare provider's top executives have exercised vested share awards, retaining a portion of the shares.
SPI
NEUTRALSpire Healthcare Group Releases 2024 Annual Report
The healthcare provider has published its 2024 annual report, providing an update on its financial and operational performance for the year.
SPI
GOODSpire Healthcare Expands Occupational Health Services with Acorn Acquisition
The healthcare provider has acquired Acorn Occupational Health, a national provider of Occupational Health services, to expand its Primary Care Services business.
SPI
NEUTRALSpire Healthcare Grants LTIP Awards to Executives
The healthcare provider has granted performance share awards to its top executives under the company's Long Term Incentive Plan.
SPI
NEUTRALSpire Healthcare Grants Deferred Share Bonus Awards to Executives
The healthcare provider has granted deferred share bonus awards to its top executives as part of their 2024 compensation.